Mikael Horissian

Mikael Horissian practices at Geisinger Medical Center in Danville, Pennsylvania, part of Risant Health.

Mikael Horissian's NPI, 1720548142, was assigned on March 21, 2019. Mikael Horissian holds Pennsylvania license MD480408.

Mikael Horissian's primary practice is Geisinger Medical Center, at 100 North Academy Avenue, Danville, PA 17822 in Montour County. The practice phone is (570) 271-6211.

Mikael Horissian's primary practice is Geisinger Medical Center in Danville, Pennsylvania, part of Risant Health. The medical group on file is Geisinger. Dmand AI also links Mikael Horissian to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Mikael Horissian practices. Vendor and product names are available with a free account.

Dermatology is Mikael Horissian's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Mikael Horissian is licensed in Pennsylvania.

CMS data shows 1,478 Medicare services from Mikael Horissian across 17 procedure codes in 2024, for 623 Medicare patients. Medicare paid $49,932 for them. Every service was in an office.

CMS counts 623 Medicare patients who saw Mikael Horissian in 2024. The largest group is 65 to 74, with 291 patients. 74% of them have high cholesterol, and 67% have high blood pressure. 9% are also on Medicaid. Their average risk score is 1.16, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Mikael Horissian's median patient age at 70, with 50% women.

In 2024, Mikael Horissian wrote 420 Medicare Part D claims for 208 patients. 80% of them were for generic drugs. CMS names the drug for 283 of them, across 9 drugs with 11 or more claims each, at $388,433 in total drug cost. In 2023, CMS named 301 claims across 13 drugs.

Mikael Horissian accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 305 procedures of removal of skin lesions by Mikael Horissian, more than 82% of the clinicians it reports for that procedure.

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 9 papers to Mikael Horissian, published from 2016 to 2025. 2023 was the busiest year, with 2. The most frequent topics are Hidradenitis Suppurativa. Mikael Horissian has published most often in J Am Acad Dermatol. Mikael Horissian's most frequent co-authors are Christen Botros Samaan, MD, Todd Vincent Cartee, MD and Matthew F. Helm, MD.

CMS Open Payments shows 71 general payments to Mikael Horissian from 9 drug and device companies from 2021 to 2025. Speaker and faculty fees make up the largest share, 77% of the total. UCB, Inc. paid the most, $34,843.